Browsing by Keyword : Receptors, Progesterone
Showing results 1 to 11 of 11
Pub Year | | Title | AJOU Author(s) |
2012 | | Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients | 김구상 |
2002 | | Donor specific response of estrogen and progesterone on cultured human melanocytes. | 강원형, 김완기, 이은소, 임성빈 |
2020 | | Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer | 정용식 |
2005 | | Expression of female sex hormone receptors in human middle-ear cholesteatomas. | 박기현, 정연훈 |
2013 | | Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression. | 강석윤, 김장희, 박태준, 임현이, 정용식 |
2021 | | Implications of tamoxifen resistance in palbociclib efficacy for patients with hormone receptor-positive, her2-negative metastatic breast cancer: Subgroup analyses of kcsg-br15-10 (youngpearl) | 강석윤 |
2014 | | MET expression is associated with disease-specific survival in breast cancer patients in the neoadjuvant setting. | 고영화 |
2010 | | Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. | 강희영, 김유찬, 이은소, 장용현 |
2019 | | Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial | 강석윤 |
2014 | | Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting. | 고영화 |
2022 | | Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population | 정용식 |
1